Literature DB >> 3953221

Anal manometric evaluation in anal fissure. Effect of anal dilation and lateral subcutaneous sphincterotomy.

K M Hiltunen, M Matikainen.   

Abstract

Anal manometry was performed in 41 patients with chronic anal fissure in order to detect possible abnormalities of sphincter function. Comparisons were made with controls matched for sex and age. The maximal basal pressure was significantly higher in the patients with anal fissure, but no other abnormality of anal sphincter function was found in these patients. Clinical and manometric results were evaluated after 2 months in 19 patients treated with anal dilation and in 14 with lateral subcutaneous sphincterotomy. After both procedures the basal pressure was significantly reduced, but there were four failures, all after anal dilation. The study supports the view that increased pressure in the anal canal contributes in the pathophysiology of anal fissure. The condition can be managed by anal dilation or lateral subcutaneous sphincterotomy, both of which effectively reduce the basal pressure in the anal canal.

Entities:  

Mesh:

Year:  1986        PMID: 3953221

Source DB:  PubMed          Journal:  Acta Chir Scand        ISSN: 0001-5482


  3 in total

1.  A manometric study of anal fissure treated by subcutaneous lateral internal sphincterotomy.

Authors:  M J McNamara; J P Percy; I R Fielding
Journal:  Ann Surg       Date:  1990-02       Impact factor: 12.969

2.  Anal sphincter function after treatment of fissure-in-ano by lateral subcutaneous sphincterotomy versus anal dilatation. A randomized study.

Authors:  J Olsen; P E Mortensen; I Krogh Petersen; J Christiansen
Journal:  Int J Colorectal Dis       Date:  1987-08       Impact factor: 2.571

Review 3.  Operative and medical treatment of chronic anal fissures-a review and network meta-analysis of randomized controlled trials.

Authors:  Sabrina Maria Ebinger; Julia Hardt; René Warschkow; Bruno Martin Schmied; Alexander Herold; Stefan Post; Lukas Marti
Journal:  J Gastroenterol       Date:  2017-04-10       Impact factor: 7.527

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.